Endometrial Cancer Recurrence Risk Following Robotic Hysterectomy
Current Oncology · 28.05.2026 · 33 (6) · 317
DOI: 10.3390/curroncol33060317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 28.05.2026. Verfasst von Sean Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cumming School of Medicine, University of Calgary, Foothills Medical Centr…. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Endometrial Neoplasms, Hysterectomy, Robotic Surgical Procedures. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Minimally invasive surgery is widely used in endometrial cancer management, but recurrence remains a concern.
Methods
A retrospective review of 1201 patients treated from 2012 to 2019 with robotic laparoscopy was conducted. Recurrence-free survival and hazard ratios were calculated using multivariate Cox models.
Results
Of 1278 patients, 155 cases of recurrent disease were identified. Age (HR 1.01, p = 0.045), LVSI (HR 3.54, p < 0.001), stage and high-grade histology (HR 3.39, p < 0.001) were associated with increased risk of recurrence. Hazard ratios for stages IB, II and III/IV were 1.92 (p = 0.007), 2.67 (p = 0.001), and 3.23 (p < 0.001) respectively. The use of a uterine manipulator was an independent risk factor on multivariate analysis (HR 2.12, p < 0.001). Adjuvant chemotherapy (HR 0.67, p = 0.239) and radiotherapy (HR 0.64, p = 0.056) trends favored reduced risk but were not significant. Chemoradiotherapy was found to have a reduction in recurrence with a HR 0.44 (p = 0.002).
Conclusions
Traditional prognostic factors remain important for patients with endometrial cancer having undergone robotic laparoscopic hysterectomy. Uterine manipulator use should be carefully reconsidered in endometrial cancer surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cumming School of Medicine, University of Calgary, Foothills Medical Centre, 1403 29 Street NW, Calgary, AB T2N 2T9, Canada.
- Division of Radiation Oncology, Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, Cross Cancer Institute, 11560 University Avenue NW, Edmonton, AB T6G 1Z2, Canada.
- Faculty of Medicine and Dentistry, University of Alberta, Walter C. Mackenzie Health Sciences Centre, 8440 112 Street NW, Edmonton, AB T6G 2R7, Canada.
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, University of Alberta, Cross Cancer Institute, 11560 University Avenue NW, Edmonton, AB T6G 1Z2, Canada.
ORCID-Profile: Haley Frerichs, Sophia Pin
Zitieren
APA
Zhu, S., Wiebe, E., Frerichs, H., Ghosh, S., Gill, J., Habsi, Z. A., Beruar, A., & Pin, S. (2026). Endometrial Cancer Recurrence Risk Following Robotic Hysterectomy. Current Oncology, 33(6), 317. https://doi.org/10.3390/curroncol33060317
Vancouver
Zhu S, Wiebe E, Frerichs H, Ghosh S, Gill J, Habsi ZA, et al. Endometrial Cancer Recurrence Risk Following Robotic Hysterectomy. Current Oncology. 2026;33(6):317. doi:10.3390/curroncol33060317
BibTeX
@article{Zhu2026,
author = {Zhu, Sean and Wiebe, Ericka and Frerichs, Haley and Ghosh, Sunita and Gill, Jasmine and Habsi, Zainab Al and Beruar, Ananya and Pin, Sophia},
title = {Endometrial Cancer Recurrence Risk Following Robotic Hysterectomy},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {6},
pages = {317},
doi = {10.3390/curroncol33060317}
}
EUVIMED